Suchergebnisse - "Lee, Hans C"

PubPharm (131)

1

Impact of prior lenalidomide or proteasome inhibitor exposure on the effectiveness of ixazomib-lenalidomide-dexamethasone for relapsed/refractory multiple myeloma : A pooled analysis from the INSURE study

enthalten in: European journal of haematology | 2024

von Lee, H. | Ramasamy, K. | Macro, M. | +10

2

INSURE : a pooled analysis of ixazomib-lenalidomide-dexamethasone for relapsed/refractory myeloma in routine practice

enthalten in: Future oncology (London, England) | 2024

von Leleu, X. | Lee, H. | Zonder, J. | +10

3

Management and Outcomes of Patients with Refractory Solitary Plasmacytoma after Treatment with Definitive Radiation Therapy

enthalten in: International journal of radiation oncology, biology, physics | 2024

von Fang, P. | Pinnix, C. | Wu, S. | +11

4

Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation

enthalten in: Cancer | 2024

von Pasvolsky, O. | Pasyar, S. | Bassett, R. | +17

5

Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation

enthalten in: British journal of haematology | 2024

von Alzahrani, K. | Pasvolsky, O. | Wang, Z. | +18

6

Real-World Utilization of Radiation Therapy in Multiple Myeloma : An Analysis of the Connect MM Registry

enthalten in: Practical radiation oncology | 2024

von Ballas, L. | Ailawadhi, S. | Narang, M. | +14

7

Novel Anti-B-cell Maturation Antigen Alpha-Amanitin Antibody-drug Conjugate HDP-101 Shows Superior Activity to Belantamab Mafodotin and Enhanced Efficacy in Deletion 17p Myeloma Models

enthalten in: Research square | 2024

von Singh, R. | Jones, R. | Shirazi, F. | +11

8

Novel Anti-B-cell Maturation Antigen Alpha-Amanitin Antibody-drug Conjugate HDP-101 Shows Superior Activity to Belantamab Mafodotin and Enhanced Efficacy in Deletion 17p Myeloma Models

enthalten in: ResearchSquare.com | 2024

von Singh, R. | Jones, R. | Shirazi, F. | +11

9

Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant : the MD Anderson cancer center experience

enthalten in: Blood cancer journal | 2024

von Pasvolsky, O. | Ghanem, S. | Milton, D. | +20

10

In-class transition from bortezomib-based therapy to IRd is an effective approach in newly diagnosed multiple myeloma

enthalten in: Future oncology (London, England) | 2024

von Rifkin, R. | Costello, C. | Birhiray, R. | +11

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]